China Biotechnology And Pharmaceutical Services Outsourcing Market Size & Outlook
China biotechnology and pharmaceutical services outsourcing market, 2018-2030 (US$M)
Related Markets
China biotechnology and pharmaceutical services outsourcing market highlights
- The China biotechnology and pharmaceutical services outsourcing market generated a revenue of USD 5,732.2 million in 2023 and is expected to reach USD 8,797.2 million by 2030.
- The China market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, consulting was the largest revenue generating services in 2023.
- Product Design & Development is the most lucrative services segment registering the fastest growth during the forecast period.
Biotechnology and pharmaceutical services outsourcing market data book summary
| Market revenue in 2023 | USD 5,732.2 million |
| Market revenue in 2030 | USD 8,797.2 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Consulting |
| Fastest growing segment | Product Design & Development |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
| Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
Other key industry trends
- In terms of revenue, China accounted for 12.4% of the global biotechnology and pharmaceutical services outsourcing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biotechnology and pharmaceutical services outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 6,530.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology And Pharmaceutical Services Outsourcing Market Scope
Biotechnology And Pharmaceutical Services Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China biotechnology and pharmaceutical services outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 48.55% in 2024. Horizon Databook has segmented the China biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the most lucrative biotechnology and pharmaceutical service outsourcing markets. Growth can be attributed to the country’s adherence to GCP guidelines and providing security & assurance to pharmaceutical & biotechnology companies about quality.
Moreover, stringent standards around patient safety in conducting clinical trials, easy access to a large patient pool, and cheap labor are other key factors expected to propel growth.
In addition, low operating costs, increasing investments to improve technology, and the rising adoption of global R&D standards to meet international requirements are key factors responsible for the growing demand for outsourcing services in China.
Reasons to subscribe to China biotechnology and pharmaceutical services outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China biotechnology and pharmaceutical services outsourcing market databook
-
Our clientele includes a mix of biotechnology and pharmaceutical services outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into China biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China biotechnology and pharmaceutical services outsourcing market size, by services, 2018-2030 (US$M)
China Biotechnology And Pharmaceutical Services Outsourcing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
